Antabuse in Severe Alcoholism: an Open Controlled Study
Primary Purpose
Alcoholism
Status
Unknown status
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
antabuse (disulfiram)
Sponsored by

About this trial
This is an interventional treatment trial for Alcoholism focused on measuring alcoholism, antabuse, disulfiram, abstinence, cognitive behavioural therapy
Eligibility Criteria
Inclusion Criteria:
- Alcoholism
- Living in the departments catchment area
Exclusion Criteria:
- Pregnancy
- Schizophrenia
- Bipolar disorder
- Other substance abuse
- Dementia
- Anorexia
Sites / Locations
- Psykiatrisk Center GentofteRecruiting
Outcomes
Primary Outcome Measures
The number of patients in each group who have not been drinking alcohol after 6 months of treatment.
Secondary Outcome Measures
Full Information
NCT ID
NCT00431262
First Posted
February 1, 2007
Last Updated
March 2, 2007
Sponsor
Psykiatrisk Center Gentofte
1. Study Identification
Unique Protocol Identification Number
NCT00431262
Brief Title
Antabuse in Severe Alcoholism: an Open Controlled Study
Official Title
Antabuse in Severe Alcoholism: an Open Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
March 2007
Overall Recruitment Status
Unknown status
Study Start Date
February 2007 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
June 2009 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Psykiatrisk Center Gentofte
4. Oversight
5. Study Description
Brief Summary
Newly detoxified alcoholics (N=60) are randomised to either antabuse (disulfiram) treatment or the control group for a total of 6 months.All patients will receive cognitive behavioural treatment in groups. The hypothesis to be tested is that more of the patients who receive antabuse (disulfiram) will be alcohol free during the 6 months treatment period compared to the control group. The trial is open.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alcoholism
Keywords
alcoholism, antabuse, disulfiram, abstinence, cognitive behavioural therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
antabuse (disulfiram)
Primary Outcome Measure Information:
Title
The number of patients in each group who have not been drinking alcohol after 6 months of treatment.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Alcoholism
Living in the departments catchment area
Exclusion Criteria:
Pregnancy
Schizophrenia
Bipolar disorder
Other substance abuse
Dementia
Anorexia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jakob Ulrichsen, MD, ph.d.
Organizational Affiliation
Psykiatrisk Center Gentofte
Official's Role
Principal Investigator
Facility Information:
Facility Name
Psykiatrisk Center Gentofte
City
Hellerup
ZIP/Postal Code
2900
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jakob Ulrichsen, MD, ph.d.
Phone
(45) 3977 3650
Email
jaul@geh.regionh.dk
First Name & Middle Initial & Last Name & Degree
Jakob Ulrichsen, MD, ph.d.
12. IPD Sharing Statement
Learn more about this trial
Antabuse in Severe Alcoholism: an Open Controlled Study
We'll reach out to this number within 24 hrs